Rethinking ovarian cancer: recommendations for improving outcomes-Reference-Cited by-同舟云学术

Rethinking ovarian cancer: recommendations for improving outcomes

Published:2011-09-23 Issue:10 Volume:11 Page:719-725
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Vaughan Sebastian,Coward Jermaine I.,Bast Robert C.,Berchuck Andy,Berek Jonathan S.,Brenton James D.,Coukos George,Crum Christopher C.,Drapkin Ronny,Etemadmoghadam Dariush,Friedlander Michael,Gabra Hani,Kaye Stan B.,Lord Chris J.,Lengyel Ernst,Levine Douglas A.,McNeish Iain A.,Menon Usha,Mills Gordon B.,Nephew Kenneth P.,Oza Amit M.,Sood Anil K.,Stronach Euan A.,Walczak Henning,Bowtell David D.,Balkwill Frances R.

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/nrc3144.pdf

Reference86 articles.

1. McGuire, W. P. Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates. J. Clin. Oncol. 27, 4633–4634 (2009).

2. Omura, G. et al. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer 57, 1725–1730 (1986).

3. Coleman, M. P. et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377, 127–138 (2011).

4. Kurman, R. J. & Shih Ie, M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 34, 433–443 (2010).

5. Piek, J. M. et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 195, 451–456 (2001).

Cited by 1051 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of Gynaecological Cancer: Ovarian, Endometrial and Cervical;International Encyclopedia of Public Health;2025

2. The unveiled mosaic of intra-tumor heterogeneity in ovarian cancer through spatial transcriptomic technologies: A systematic review;Translational Research;2024-11

3. A 15-Gene prognostic signature with TFAP2B functioning in Platinum Resistance of Ovarian Carcinoma;2024-09-09

4. Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer;Biomarker Research;2024-08-12

5. Steroid metabolism and hormonal dynamics in normal and malignant ovaries;Essays in Biochemistry;2024-07-12